Pancreatitis Trial, Recruiting (NCT06250803)

Pancreatitis Trial, Recruiting NCT06250803 Sponsor: The First Affiliated Hospital of Anhui Medical University Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT06250803 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have a natural, previously untreated papilla (the small opening where the bile duct and pancreatic duct meet in the digestive system)
People aged 18 or older
People undergoing a procedure called ERCP, where a specific technique using a guidewire through the pancreatic duct is being used to access the bile duct
People who have given their signed, written agreement to take part

Who may not be able to join:

People whose main papilla cannot be reached during the procedure
People whose digestive system anatomy has been changed by previous surgery
People who currently have acute pancreatitis (sudden inflammation of the pancreas)
People where bile duct access is being attempted over a pancreatic duct stent following certain prior techniques (confirm with trial site)
People where the bile duct could not be successfully accessed during the procedure
People with serious, active heart or lung disease
People who are pregnant or breastfeeding
People who have a tumour at or near the papilla area

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8613865977696

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06250803

Sponsor: The First Affiliated Hospital of Anhui Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatitis

Trial contact: 8613865977696

More information: https://clinicaltrials.gov/study/NCT06250803

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have a natural, previously untreated papilla (the small opening where the bile duct and pancreatic duct meet in the digestive system)
People aged 18 or older
People undergoing a procedure called ERCP, where a specific technique using a guidewire through the pancreatic duct is being used to access the bile duct
People who have given their signed, written agreement to take part

Who may not be able to join:

People whose main papilla cannot be reached during the procedure
People whose digestive system anatomy has been changed by previous surgery
People who currently have acute pancreatitis (sudden inflammation of the pancreas)
People where bile duct access is being attempted over a pancreatic duct stent following certain prior techniques (confirm with trial site)
People where the bile duct could not be successfully accessed during the procedure
People with serious, active heart or lung disease
People who are pregnant or breastfeeding
People who have a tumour at or near the papilla area

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The First Affiliated Hospital of Anhui Medical University

Registry

ClinicalTrials.gov

Start date

1 April 2024

Est. completion

1 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The incidence and severity of post-ERCP pancreatitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov